长期质子泵抑制剂治疗的安全性与并发症：更接近真相 - Suppr

Suppr

超能文献

Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth.

作者信息

Corley Douglas A

机构信息

Kaiser Permanente, Division of Research, Oakland, California.

出版信息

Gastroenterology. 2019 Sep;157(3):604-607. doi: 10.1053/j.gastro.2019.07.039. Epub 2019 Jul 30.

DOI:10.1053/j.gastro.2019.07.039

PMID:31378636

Abstract

摘要

相似文献

Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth.

Gastroenterology. 2019 Sep;157(3):604-607. doi: 10.1053/j.gastro.2019.07.039. Epub 2019 Jul 30.

Long-term Renal Effects of Proton Pump Inhibitor Use.

Gastroenterology. 2020 Mar;158(4):1173-1174. doi: 10.1053/j.gastro.2019.07.066. Epub 2019 Dec 10.

Safety of Proton Pump Inhibitors Questioned Based on a Large Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Gastroenterology. 2020 Mar;158(4):1172-1173. doi: 10.1053/j.gastro.2019.07.067. Epub 2019 Dec 10.

What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors?

Gastroenterology. 2020 Mar;158(4):1175. doi: 10.1053/j.gastro.2019.09.053. Epub 2019 Dec 27.

Proton Pump Inhibitor Therapy and Fracture Risk: Discrepancy of Results Between Observational and Interventional Studies.

Gastroenterology. 2020 Mar;158(4):1174. doi: 10.1053/j.gastro.2019.09.054. Epub 2020 Jan 23.

Association between the use of proton pump inhibitors and cardiovascular events: A note of caution.

Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12977.

The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease.

Aliment Pharmacol Ther. 2006 Mar 15;23(6):743-9. doi: 10.1111/j.1365-2036.2006.02829.x.

[Comment. Higher safety for patients and lower costs for society].

Gac Sanit. 2006 Jan-Feb;20(1):58. doi: 10.1157/13084129.

Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin.

Expert Rev Clin Pharmacol. 2014 Sep;7(5):645-53. doi: 10.1586/17512433.2014.945428. Epub 2014 Aug 7.

Reply.

Gastroenterology. 2020 Mar;158(4):1175-1176. doi: 10.1053/j.gastro.2019.12.023. Epub 2020 Jan 7.

引用本文的文献

Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia.

Cochrane Database Syst Rev. 2025 May 8;5(5):CD014585. doi: 10.1002/14651858.CD014585.pub2.

Efficacy of cyclin-dependent kinase inhibitors with concurrent proton pump inhibitors in patients with breast cancer: a systematic review and meta-analysis.

Oncologist. 2025 Feb 6;30(2). doi: 10.1093/oncolo/oyae320.

Impact of pharmacist-evaluated clinical decision support system alerts on potentially missing or inappropriately prescribed proton pump inhibitors at hospital discharge: a retrospective cross-sectional study.

Int J Clin Pharm. 2024 Oct;46(5):1143-1151. doi: 10.1007/s11096-024-01746-6. Epub 2024 Jun 13.

The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis.

Cancers (Basel). 2023 Oct 25;15(21):5133. doi: 10.3390/cancers15215133.

The central role of gastrin in gastric cancer.

Front Oncol. 2023 Oct 24;13:1176673. doi: 10.3389/fonc.2023.1176673. eCollection 2023.

PPIs and gastric cancer: any causal relationship?

Acta Biomed. 2023 Jun 14;94(3):e2023096. doi: 10.23750/abm.v94i3.14105.

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study.

BMC Cancer. 2022 May 7;22(1):516. doi: 10.1186/s12885-022-09624-y.

Updated Insights on Cardiac and Vascular Risks of Proton Pump Inhibitors: A Real-World Pharmacovigilance Study.

Front Cardiovasc Med. 2022 Feb 25;9:767987. doi: 10.3389/fcvm.2022.767987. eCollection 2022.

Barriers to Guideline-Based Use of Proton Pump Inhibitors to Prevent Upper Gastrointestinal Bleeding.

Ann Fam Med. 2022 Jan-Feb;20(1):5-11. doi: 10.1370/afm.2734.

Chronic diseases: what about infections of virus and prions the gut?

Therap Adv Gastroenterol. 2021 Sep 28;14:17562848211028805. doi: 10.1177/17562848211028805. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth.

作者信息

Corley Douglas A

机构信息

Kaiser Permanente, Division of Research, Oakland, California.

出版信息

Gastroenterology. 2019 Sep;157(3):604-607. doi: 10.1053/j.gastro.2019.07.039. Epub 2019 Jul 30.

DOI:10.1053/j.gastro.2019.07.039

PMID:31378636

Abstract

摘要

相似文献

Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth.

Gastroenterology. 2019 Sep;157(3):604-607. doi: 10.1053/j.gastro.2019.07.039. Epub 2019 Jul 30.

Long-term Renal Effects of Proton Pump Inhibitor Use.

Gastroenterology. 2020 Mar;158(4):1173-1174. doi: 10.1053/j.gastro.2019.07.066. Epub 2019 Dec 10.

Safety of Proton Pump Inhibitors Questioned Based on a Large Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Gastroenterology. 2020 Mar;158(4):1172-1173. doi: 10.1053/j.gastro.2019.07.067. Epub 2019 Dec 10.

What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors?

Gastroenterology. 2020 Mar;158(4):1175. doi: 10.1053/j.gastro.2019.09.053. Epub 2019 Dec 27.

Proton Pump Inhibitor Therapy and Fracture Risk: Discrepancy of Results Between Observational and Interventional Studies.

Gastroenterology. 2020 Mar;158(4):1174. doi: 10.1053/j.gastro.2019.09.054. Epub 2020 Jan 23.

Association between the use of proton pump inhibitors and cardiovascular events: A note of caution.

Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12977.

The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease.

Aliment Pharmacol Ther. 2006 Mar 15;23(6):743-9. doi: 10.1111/j.1365-2036.2006.02829.x.

[Comment. Higher safety for patients and lower costs for society].

Gac Sanit. 2006 Jan-Feb;20(1):58. doi: 10.1157/13084129.

Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin.

Expert Rev Clin Pharmacol. 2014 Sep;7(5):645-53. doi: 10.1586/17512433.2014.945428. Epub 2014 Aug 7.

Reply.

Gastroenterology. 2020 Mar;158(4):1175-1176. doi: 10.1053/j.gastro.2019.12.023. Epub 2020 Jan 7.

引用本文的文献

Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia.

Cochrane Database Syst Rev. 2025 May 8;5(5):CD014585. doi: 10.1002/14651858.CD014585.pub2.

Efficacy of cyclin-dependent kinase inhibitors with concurrent proton pump inhibitors in patients with breast cancer: a systematic review and meta-analysis.

Oncologist. 2025 Feb 6;30(2). doi: 10.1093/oncolo/oyae320.

Int J Clin Pharm. 2024 Oct;46(5):1143-1151. doi: 10.1007/s11096-024-01746-6. Epub 2024 Jun 13.

The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis.

Cancers (Basel). 2023 Oct 25;15(21):5133. doi: 10.3390/cancers15215133.

The central role of gastrin in gastric cancer.

Front Oncol. 2023 Oct 24;13:1176673. doi: 10.3389/fonc.2023.1176673. eCollection 2023.

PPIs and gastric cancer: any causal relationship?

Acta Biomed. 2023 Jun 14;94(3):e2023096. doi: 10.23750/abm.v94i3.14105.

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study.

BMC Cancer. 2022 May 7;22(1):516. doi: 10.1186/s12885-022-09624-y.

Updated Insights on Cardiac and Vascular Risks of Proton Pump Inhibitors: A Real-World Pharmacovigilance Study.

Front Cardiovasc Med. 2022 Feb 25;9:767987. doi: 10.3389/fcvm.2022.767987. eCollection 2022.

Barriers to Guideline-Based Use of Proton Pump Inhibitors to Prevent Upper Gastrointestinal Bleeding.

Ann Fam Med. 2022 Jan-Feb;20(1):5-11. doi: 10.1370/afm.2734.

Chronic diseases: what about infections of virus and prions the gut?

Therap Adv Gastroenterol. 2021 Sep 28;14:17562848211028805. doi: 10.1177/17562848211028805. eCollection 2021.